ATE122669T1 - Zearalanol-derivate mit anabolytischer wirkung. - Google Patents

Zearalanol-derivate mit anabolytischer wirkung.

Info

Publication number
ATE122669T1
ATE122669T1 AT88309598T AT88309598T ATE122669T1 AT E122669 T1 ATE122669 T1 AT E122669T1 AT 88309598 T AT88309598 T AT 88309598T AT 88309598 T AT88309598 T AT 88309598T AT E122669 T1 ATE122669 T1 AT E122669T1
Authority
AT
Austria
Prior art keywords
anabolytic
action
hydrogen
hydroxyl
compounds
Prior art date
Application number
AT88309598T
Other languages
English (en)
Inventor
Martin J Jacobs
Original Assignee
Mallinckrodt Veterinary Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Veterinary Inc filed Critical Mallinckrodt Veterinary Inc
Application granted granted Critical
Publication of ATE122669T1 publication Critical patent/ATE122669T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D313/00Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Beans For Foods Or Fodder (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Cephalosporin Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT88309598T 1987-10-13 1988-10-13 Zearalanol-derivate mit anabolytischer wirkung. ATE122669T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/108,539 US4849447A (en) 1987-10-13 1987-10-13 Zearalanol derivatives with anabolic activity

Publications (1)

Publication Number Publication Date
ATE122669T1 true ATE122669T1 (de) 1995-06-15

Family

ID=22322783

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88309598T ATE122669T1 (de) 1987-10-13 1988-10-13 Zearalanol-derivate mit anabolytischer wirkung.

Country Status (6)

Country Link
US (1) US4849447A (de)
EP (1) EP0312353B1 (de)
JP (1) JPH01199960A (de)
AT (1) ATE122669T1 (de)
DE (1) DE3853804T2 (de)
ES (1) ES2072264T3 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5185365A (en) * 1992-06-24 1993-02-09 Cornell Research Foundation, Inc. Insect deterrent azamcrolides
JP5465006B2 (ja) 2006-08-11 2014-04-09 ユニベルシテ・ドウ・ストラスブール キナーゼおよびhsp90の阻害剤として有用な大環状化合物
ES2581765T3 (es) 2006-08-24 2016-09-07 University Of Tennessee Research Foundation Acilanilidas sustituidas y métodos de uso de las mismas
US20110190237A1 (en) * 2008-01-15 2011-08-04 Nexgenix Pharmaceuticals Macrocyclic Prodrug Compounds Useful as Therapeutics
US9622992B2 (en) 2012-07-13 2017-04-18 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US9744149B2 (en) 2012-07-13 2017-08-29 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
LT2872482T (lt) 2012-07-13 2020-12-28 Oncternal Therapeutics, Inc. Krūties vėžių gydymo būdas selektyviu androgeno receptoriaus moduliatoriumi
US10987334B2 (en) 2012-07-13 2021-04-27 University Of Tennessee Research Foundation Method of treating ER mutant expressing breast cancers with selective androgen receptor modulators (SARMs)
US10258596B2 (en) 2012-07-13 2019-04-16 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
US9969683B2 (en) 2012-07-13 2018-05-15 Gtx, Inc. Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS)
US10314807B2 (en) 2012-07-13 2019-06-11 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3453367A (en) * 1966-06-29 1969-07-01 Commercial Solvents Corp Methods for treating inflammation with estrogenic compounds
FR96016E (fr) * 1966-06-29 1972-05-19 Commercial Solvents Corp Composé utilisable comme supplément alimentaire pour les animaux.
FR96046E (fr) * 1966-06-29 1972-05-19 Commercial Solvents Corp Composé utilisable comme supplément alimentaire pour les animaux.
US3373037A (en) * 1966-06-29 1968-03-12 Commercial Solvents Corp Estrogenic compounds and animal growth promoters
US3887583A (en) * 1968-05-15 1975-06-03 Commercial Solvents Corp Products and process
US3957825A (en) * 1972-04-25 1976-05-18 Commercial Solvents Corporation Process for synthesizing zearalanone and related compounds
US4024602A (en) * 1975-02-10 1977-05-24 Actionite Company, Inc. Apparatus for decasing food links
US4148808A (en) * 1975-08-22 1979-04-10 Int Minerals & Chem Corp Method for reducing zearalenone
US4239772A (en) * 1979-05-30 1980-12-16 International Minerals & Chemical Corp. Allyl and propyl zearalenone derivatives and their use as growth promoting agents
US4443470A (en) * 1981-09-03 1984-04-17 International Minerals & Chemical Corp. Method of promoting growth and enhancing feed efficiency in meat producing animals

Also Published As

Publication number Publication date
ES2072264T3 (es) 1995-07-16
EP0312353B1 (de) 1995-05-17
EP0312353A2 (de) 1989-04-19
US4849447A (en) 1989-07-18
JPH01199960A (ja) 1989-08-11
DE3853804D1 (de) 1995-06-22
DE3853804T2 (de) 1995-11-02
EP0312353A3 (en) 1990-06-20

Similar Documents

Publication Publication Date Title
NO873939D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive retinsyrederivater.
ES2166359T3 (es) Derivado de depsipeptido, su produccion y uso.
EP0256503A3 (en) Pyridinecarboxamide derivatives and their use as fungicide
ATE223378T1 (de) Prolineamid-derivate
ATE132862T1 (de) Aryl- und heteroaryl-piperazinylcarboxamide mit wirkung auf das zentrale nervensystem
FI914187A0 (fi) Menetelmä valmistaa kaavan /I/ mukaista 1-metyylikarbapeneemijohdosta
ATE122669T1 (de) Zearalanol-derivate mit anabolytischer wirkung.
DE69215694D1 (de) Benzamid-derivate
DE3665711D1 (de) Novel guanidinomethylbenzoic acid derivatives
DE69125360D1 (de) Alkylester von oxidiertem Glutathion
SE8100403L (sv) Cyklohexen-derivat
FR2681864B1 (fr) Nouveaux derives bicycliques azotes, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
DE69123757D1 (de) Epoxysuccinamidsäurederivat
AR246965A1 (es) Procedimiento para fabricar un derivado del acido 1-3-dioxan-alquenoico.
SE8200679L (sv) 1-bensyl-4-(4-(2-pyrimidinylamino) bensyl 1-2,3-dioxopiperazinderivat, salter derav, forfarande for framstellning derav och karcinostatiska medel der de ingar
IE873442L (en) Cephalosporin derivative
ES2096628T3 (es) Derivados heterociclicos.
ATE53163T1 (de) Desinfektionszusammensetzungen.
EG18407A (en) Stable injectable antiemetic compositions
ES2059097T3 (es) Derivados de la ergolina.
DE3782229D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties